122 related articles for article (PubMed ID: 2091183)
41. [Intravenous immunoglobulin preparations in the adjuvant treatment of acute lymphoblastic leukemia in children].
Rokicka-Milewska R; Derulska D; Skwarska E
Pol Tyg Lek; 1988 Aug; 43(34):1085-7. PubMed ID: 3150782
[No Abstract] [Full Text] [Related]
42. [Treatment of infantile acute lymphoblastic leukemia with protocol ALL-BFM 83].
Aracil Santos FJ; Bernacer Borja M; López Pérez J; Melero Moreno C; Valverde Moreno F; Gil Gil C; Contra Gómez T; Martín Ramos N
An Esp Pediatr; 1989 Oct; 31(4):362-7. PubMed ID: 2627059
[TBL] [Abstract][Full Text] [Related]
43. Biology and therapy of childhood acute lymphoblastic leukemia.
Rivera GK; Crist WM; Sallan SE
Rev Invest Clin; 1994 Apr; Suppl():26-33. PubMed ID: 7886304
[No Abstract] [Full Text] [Related]
44. Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission.
Barrett AJ; Horowitz MM; McCarthy DM; Kanfer E; Bortin MM
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():247-9. PubMed ID: 2653514
[No Abstract] [Full Text] [Related]
45. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
46. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
47. Emergency consent: medical care for the minor.
Winer R
J Kans Med Soc; 1981 Oct; 82(10):458-62, 472. PubMed ID: 7334271
[No Abstract] [Full Text] [Related]
48. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
49. [High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children].
Makhonova LA; Maiakova SA; Kiselev AV; Gordina GA; Balakirev SA; Gavrilova IE; Moiseenko EI; Morozova OV
Vopr Onkol; 1990; 36(10):1196-200. PubMed ID: 2251813
[TBL] [Abstract][Full Text] [Related]
50. Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.
Kudva GC; Chandy M; Raghupathy P; Dennison D; Srivastava A; Bhushan V; Singh R
Indian J Cancer; 1994 Jun; 31(2):78-85. PubMed ID: 7927453
[TBL] [Abstract][Full Text] [Related]
51. Recent developments in medical care of Jehovah's Witnesses.
Muramoto O
West J Med; 1999 May; 170(5):297-301. PubMed ID: 10379225
[No Abstract] [Full Text] [Related]
52. Jehovah's Witnesses with leukaemia.
Cullis JO; Smith AG
Lancet; 1990 Oct; 336(8722):1075-6. PubMed ID: 1977056
[No Abstract] [Full Text] [Related]
53. Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient.
Chojnowski K; Janus A; Bliźniewska K; Robak M; Treliński J
Transfusion; 2016 Oct; 56(10):2438-2442. PubMed ID: 27385671
[TBL] [Abstract][Full Text] [Related]
54. Successful treatment for acute lymphoblastic leukemia without blood transfusion in a Jehovah's Witness.
Takeuchi S; Utsunomiya A; Makino T; Shimotakahara S; Takatsuka Y; Kawabata H; Nakashima A
Am J Hematol; 1999 Feb; 60(2):168-9. PubMed ID: 9929116
[No Abstract] [Full Text] [Related]
55. Acute lymphocytic leukemia presenting as an isolated scalp nodule in an infant.
Anderson PC; Stotland MA; Dinulos JG; Perry AE
Ann Plast Surg; 2010 Feb; 64(2):251-3. PubMed ID: 20098116
[TBL] [Abstract][Full Text] [Related]
56. Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia?
Jaime-Pérez JC; Colunga-Pedraza PR; Gómez-Almaguer D
Pediatr Blood Cancer; 2011 Aug; 57(2):217-23. PubMed ID: 21671359
[TBL] [Abstract][Full Text] [Related]
57. How to improve the informed consent process.
Masera G; D'Angio G
Pediatr Blood Cancer; 2010 Jul; 55(1):10-1. PubMed ID: 20486165
[No Abstract] [Full Text] [Related]
58. Insidious iron burden in pediatric patients with acute lymphoblastic leukemia.
Eng J; Fish JD
Pediatr Blood Cancer; 2011 Mar; 56(3):368-71. PubMed ID: 21072815
[TBL] [Abstract][Full Text] [Related]
59. Should Jehovah's Witnesses be denied intensive chemotherapy for acute leukemia?
Goldberg SL; Chan CS; Dawkins FW; Mehlman TW; Schechter GP
N Engl J Med; 1990 Mar; 322(11):777-8. PubMed ID: 2308609
[No Abstract] [Full Text] [Related]
60. Use of platelet and erythroid growth factors during induction chemotherapy for acute lymphoblastic leukaemia in a Jehovah's Witness.
Arora N; Gupta A; Li HC; Sadeghi N
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
